chapter 19 pulmonary function testing
DESCRIPTION
Chapter 19 Pulmonary Function Testing. Learning Objectives. List the three categories of pulmonary function tests. State the primary purposes of pulmonary function testing. Describe the pathophysiologic patterns associated with obstructive and restrictive lung disease. - PowerPoint PPT PresentationTRANSCRIPT
Copyright © 2013, 2009, 2003, 1999, 1995, 1990, 1982, 1977, 1973, 1969 by Mosby, an imprint of Elsevier Inc.
Chapter 19
Pulmonary Function Testing
Copyright © 2013, 2009, 2003, 1999, 1995, 1990, 1982, 1977, 1973, 1969 by Mosby, an imprint of Elsevier Inc.
Learning Objectives
• List the three categories of pulmonary function tests.
• State the primary purposes of pulmonary function testing.
• Describe the pathophysiologic patterns associated with obstructive and restrictive lung disease.
• State what is meant by the term spirometer, and list the parameters that can be measured by it.
2
Copyright © 2013, 2009, 2003, 1999, 1995, 1990, 1982, 1977, 1973, 1969 by Mosby, an imprint of Elsevier Inc.
Learning Objectives (cont.)
• List and describe the four general principles that should be considered for tests of pulmonary function.
• List and describe the measurements that indicate pulmonary mechanics.
• Describe the purpose and technique for the bronchial challenge test.
• List and describe the four volumes and four capacities that can be measured with pulmonary function testing.
3
Copyright © 2013, 2009, 2003, 1999, 1995, 1990, 1982, 1977, 1973, 1969 by Mosby, an imprint of Elsevier Inc.
Learning Objections (cont.)
• Describe the purpose and techniques used to measure diffusion capacity.
• Interpret pulmonary function reports.
4
Copyright © 2013, 2009, 2003, 1999, 1995, 1990, 1982, 1977, 1973, 1969 by Mosby, an imprint of Elsevier Inc.
PFTs will measure:
• Dynamic flow rates of gases through airways,
• Lung volumes & capacities
• Ability of lungs to diffuse gases
5
Copyright © 2013, 2009, 2003, 1999, 1995, 1990, 1982, 1977, 1973, 1969 by Mosby, an imprint of Elsevier Inc.
Purposes of PFT
• Identify & quantify changes in pulmonary function due to disease
• Evaluate effectiveness of therapy• Perform epidemiological surveillance for
pulmonary disease• Assess patients for risk of postoperative
complications• Determine pulmonary disability
6
Copyright © 2013, 2009, 2003, 1999, 1995, 1990, 1982, 1977, 1973, 1969 by Mosby, an imprint of Elsevier Inc. 7
All of the following are contraindications to pulmonary function testing, except:
A. Hypertension
B. Pneumothorax
C. Pulmonary Embolism
D. Myocardial Infarction
Copyright © 2013, 2009, 2003, 1999, 1995, 1990, 1982, 1977, 1973, 1969 by Mosby, an imprint of Elsevier Inc.
Pathophysiologic Patterns
• Two major categories of pulmonary disease exist: ObstructiveRestrictive
• Primary abnormality in obstructive disease is increased airways resistance
• Primary problem in restrictive disease is decrease in either lung compliance or lung volumes or both
• Some pulmonary diseases cause both obstructive & restrictive disease
8
Copyright © 2013, 2009, 2003, 1999, 1995, 1990, 1982, 1977, 1973, 1969 by Mosby, an imprint of Elsevier Inc.
Pathophysiologic Patterns
9
Copyright © 2013, 2009, 2003, 1999, 1995, 1990, 1982, 1977, 1973, 1969 by Mosby, an imprint of Elsevier Inc.
PFT Equipment
• Two general types of measuring devices exist, those that:Measure volumeMeasure flow
• Volume-measuring devices - spirometers• Flow-measuring devices - pneumotachometers• Every measuring device has capacity, accuracy,
error, resolution, precision, linearity, & output
10
Copyright © 2013, 2009, 2003, 1999, 1995, 1990, 1982, 1977, 1973, 1969 by Mosby, an imprint of Elsevier Inc.
Elements of Quality Assurance
Accuracy & precision of measuring instruments
Performance of Respiratory Therapist (RT) Test results when measuring a standard
11
Copyright © 2013, 2009, 2003, 1999, 1995, 1990, 1982, 1977, 1973, 1969 by Mosby, an imprint of Elsevier Inc. 12
All of the following are pathophysiological patterns of pulmonary diseases, except:
A. Restrictive diseases will decrease lung compliance
B. Obstructive diseases will increase airway resistance
C. Restrictive disease will increase lung volumes
D. Some pulmonary diseases can cause both obstructive and restrictive disease
Copyright © 2013, 2009, 2003, 1999, 1995, 1990, 1982, 1977, 1973, 1969 by Mosby, an imprint of Elsevier Inc.
Principles of Measurement
• Most pulmonary function laboratories have 3 components.1. Performing spirometry to measure airway
mechanics2. Measuring lung volumes & capacities3. Measuring diffusion capacity of lung
• All 3 components are required when purpose of PFT is to identify presence & degree of pulmonary impairment
13
Copyright © 2013, 2009, 2003, 1999, 1995, 1990, 1982, 1977, 1973, 1969 by Mosby, an imprint of Elsevier Inc.
Spirometry
• Tests of pulmonary mechanicsForced vital capacity (FVC)Forced expiratory volume in 1 second (FEV1)
Other forced expiratory flow measurementsMaximum voluntary ventilation
• These measurements assess ability of lungs to move large volumes of air quickly through airways
14
Copyright © 2013, 2009, 2003, 1999, 1995, 1990, 1982, 1977, 1973, 1969 by Mosby, an imprint of Elsevier Inc.
Forced Vital Capacity
• Most common test of pulmonary mechanics• Many measurements are made while patient is
performing FVC maneuver• FVC is an effort-dependent maneuver requiring
careful patient instruction & cooperation• To ensure validity, each patient must perform at
least 3 acceptable FVC maneuvers
15
Copyright © 2013, 2009, 2003, 1999, 1995, 1990, 1982, 1977, 1973, 1969 by Mosby, an imprint of Elsevier Inc.
Forced Vital Capacity (cont.)
16
Copyright © 2013, 2009, 2003, 1999, 1995, 1990, 1982, 1977, 1973, 1969 by Mosby, an imprint of Elsevier Inc.
Other Measures of Pulmonary Mechanics
• FEV1 - volume of gas exhaled in first 1-second of FVC maneuver
• FEV1/FVC - calculated by dividing largest FEV1 by largest FVC
• FEF200-1200 - average flow rate early in FVC maneuver
• FEF25-75 - measure of flow during middle 50% of FVC
• PEFR - highest point on flow-volume graph
17
Copyright © 2013, 2009, 2003, 1999, 1995, 1990, 1982, 1977, 1973, 1969 by Mosby, an imprint of Elsevier Inc.
Pulmonary Mechanics
18
Copyright © 2013, 2009, 2003, 1999, 1995, 1990, 1982, 1977, 1973, 1969 by Mosby, an imprint of Elsevier Inc.
Pulmonary Mechanics
19
Copyright © 2013, 2009, 2003, 1999, 1995, 1990, 1982, 1977, 1973, 1969 by Mosby, an imprint of Elsevier Inc.
Pulmonary Mechanics
20
Copyright © 2013, 2009, 2003, 1999, 1995, 1990, 1982, 1977, 1973, 1969 by Mosby, an imprint of Elsevier Inc. 21
What is the most commonly used test of pulmonary mechanics:
A. Forced expiratory flow measurements (FEV1)
B. Forced vital capacity (FVC)
C. Maximum voluntary ventilation (MVV)
D. Helium dilution technique
Copyright © 2013, 2009, 2003, 1999, 1995, 1990, 1982, 1977, 1973, 1969 by Mosby, an imprint of Elsevier Inc.
Maximal Voluntary Ventilation (MVV)
• Effort-dependent test; patient asked to breathe deep & fast for 12 seconds
• Results reflect:Patient effortFunction of respiratory musclesAbility of chest wall to expandPatency of airways
22
Copyright © 2013, 2009, 2003, 1999, 1995, 1990, 1982, 1977, 1973, 1969 by Mosby, an imprint of Elsevier Inc.
The MVV (cont.)
23
Copyright © 2013, 2009, 2003, 1999, 1995, 1990, 1982, 1977, 1973, 1969 by Mosby, an imprint of Elsevier Inc.
Quality Assurance of Spirometry
3.0 L syringe used for accuracy & precision of volume or flow Multiple strokes at various injection speeds Average volume should meet the +/- 3% standard 95% expected performance range should be
determined Technologist performance should be
observed & reviewed periodically
24
Copyright © 2013, 2009, 2003, 1999, 1995, 1990, 1982, 1977, 1973, 1969 by Mosby, an imprint of Elsevier Inc.
Significance of Results
• Normal FEV1 = 5.6 L for average 20-year-old man
• FEV1 is reduced with both obstructive & restrictive lung disease.
• FEV1/FVC should be at least 70% Reduced with obstructive disease Normal with restrictive disease
• Other measures of expiratory flow are also reduced when obstructive disease is present
25
Copyright © 2013, 2009, 2003, 1999, 1995, 1990, 1982, 1977, 1973, 1969 by Mosby, an imprint of Elsevier Inc.
Significance of Results (cont.)
• Normal MVV for males is 160 to 180 L/min & slightly lower in females
• MVV is reduced in patients with moderate to severe obstructive lung disease
• MVV may be normal or slightly reduced in patients with restrictive disease
• Undernourished patients may have reduced MVV
26
Copyright © 2013, 2009, 2003, 1999, 1995, 1990, 1982, 1977, 1973, 1969 by Mosby, an imprint of Elsevier Inc.
Obstructive & Restrictive Disorders
27
Copyright © 2013, 2009, 2003, 1999, 1995, 1990, 1982, 1977, 1973, 1969 by Mosby, an imprint of Elsevier Inc.
Obstructive & Restrictive Disorders
28
Copyright © 2013, 2009, 2003, 1999, 1995, 1990, 1982, 1977, 1973, 1969 by Mosby, an imprint of Elsevier Inc.
Obstructive & Restrictive Disorders
29
Copyright © 2013, 2009, 2003, 1999, 1995, 1990, 1982, 1977, 1973, 1969 by Mosby, an imprint of Elsevier Inc.
Reversibility
• If obstruction is present, reversibility must be evaluated
• Done by performing spirometry before & after therapy
• Bronchodilator is administered by small-volume nebulizer or MDI
• Reversibility indicates effective therapy• Reversibility is defined as 15% or greater
improvement in FEV1 & at least 200-ml increase in FEV1
30
Copyright © 2013, 2009, 2003, 1999, 1995, 1990, 1982, 1977, 1973, 1969 by Mosby, an imprint of Elsevier Inc. 31
If FEV1/FVC is less than 70%, this would indicate;
A. Obstructive disease
B. Obstructive and restrictive disease
C. Restrictive disease
D. Patient is in the normal range
Copyright © 2013, 2009, 2003, 1999, 1995, 1990, 1982, 1977, 1973, 1969 by Mosby, an imprint of Elsevier Inc.
Lung Volumes & Capacities
Lung VolumesTidal volumeInspiratory reserve
volumeExpiratory reserve
volumeResidual volume
Lung CapacitiesTotal lung capacityInspiratory capacityFunctional residual
capacityVital capacity
32
Copyright © 2013, 2009, 2003, 1999, 1995, 1990, 1982, 1977, 1973, 1969 by Mosby, an imprint of Elsevier Inc.
Lung Volumes & Capacities (cont.)
33
Copyright © 2013, 2009, 2003, 1999, 1995, 1990, 1982, 1977, 1973, 1969 by Mosby, an imprint of Elsevier Inc. 34
The functional residual capacity consist of which two lung volumes
A. Tidal volume and inspiratory reserve volume
B. Tidal volume and expiratory reserve volume
C. Inspiratory reserve volume and residual volume
D. Expiratory reserve volume and residual volume
Copyright © 2013, 2009, 2003, 1999, 1995, 1990, 1982, 1977, 1973, 1969 by Mosby, an imprint of Elsevier Inc.
Techniques for Measuring RV
• Helium dilutionBased on fact that known amount of helium will be
diluted by size of patient’s RV
• Nitrogen washoutBased on fact that 79% of RV is nitrogenVolume of nitrogen exhaled ÷ 0.79 = RV
• Body boxApplies Boyle’s law to measure RV
35
Copyright © 2013, 2009, 2003, 1999, 1995, 1990, 1982, 1977, 1973, 1969 by Mosby, an imprint of Elsevier Inc.
Quality Assurance for Measuring Lung Volume
Helium dilution & nitrogen washout Accuracy & precision of volume & flow measuring
device Accuracy & linearity of gas analyzer Leak test must be acceptable range
Plethysmography Box & mouth pressure transducers must be
calibrated & accurate
36
Copyright © 2013, 2009, 2003, 1999, 1995, 1990, 1982, 1977, 1973, 1969 by Mosby, an imprint of Elsevier Inc.
Helium Dilution
37
Copyright © 2013, 2009, 2003, 1999, 1995, 1990, 1982, 1977, 1973, 1969 by Mosby, an imprint of Elsevier Inc.
Nitrogen Washout
38
Copyright © 2013, 2009, 2003, 1999, 1995, 1990, 1982, 1977, 1973, 1969 by Mosby, an imprint of Elsevier Inc.
Body Plethymography
39
Copyright © 2013, 2009, 2003, 1999, 1995, 1990, 1982, 1977, 1973, 1969 by Mosby, an imprint of Elsevier Inc.
Significance of Results
• TLC, FRC, & RV increase with obstructive disease & decrease with restrictive impairment
• Normal tidal volume is 500 to 700 ml (5 to 8 ml/kg of predicted body weight); VT measurement alone not helpful
• Normal TLC is about 6 L• Normal VC is about 4.8 L in adult; results vary
with age, gender, height, & ethnicity
40
Copyright © 2013, 2009, 2003, 1999, 1995, 1990, 1982, 1977, 1973, 1969 by Mosby, an imprint of Elsevier Inc.
Changes With Lung Disease
41
Copyright © 2013, 2009, 2003, 1999, 1995, 1990, 1982, 1977, 1973, 1969 by Mosby, an imprint of Elsevier Inc.
Diffusing Capacity
• Most PF labs use carbon monoxide to measure the diffusion capacity of the lungs
• Results reported in ml/min/mm Hg• Results may be low in both obstructive &
restrictive lung disease• Emphysema & pulmonary fibrosis are two
common causes of reduced DLCO
42
Copyright © 2013, 2009, 2003, 1999, 1995, 1990, 1982, 1977, 1973, 1969 by Mosby, an imprint of Elsevier Inc.
Single Breath Technique
43
Copyright © 2013, 2009, 2003, 1999, 1995, 1990, 1982, 1977, 1973, 1969 by Mosby, an imprint of Elsevier Inc.
Interpreting the DLCO
Factors that Decrease DLCO
• Anemia• Carboxyhemoglobin• Pulmonary
Embolism• Diffused pulmonary
fibrosis• Pulmonary
emphysema
Factors that Increase DLCO
PolycythemiaExerciseCongestive heart
failure
44
Copyright © 2013, 2009, 2003, 1999, 1995, 1990, 1982, 1977, 1973, 1969 by Mosby, an imprint of Elsevier Inc.
Quality Assurance for Measuring Diffusing Capacity
Accuracy & precision of volume or flow measuring device
Accuracy & linearity of gas analyzer Test acceptability & repeatability Measuring diffusing capacity of 3.0 L to
provide quality control standard
45
Copyright © 2013, 2009, 2003, 1999, 1995, 1990, 1982, 1977, 1973, 1969 by Mosby, an imprint of Elsevier Inc. 46
Which one of these factors can decrease the diffusing capacity of the lung:
A. Polycythemia.
B. Exercise.
C. Congestive heart failure.
D. Pulmonary emphysema.
Copyright © 2013, 2009, 2003, 1999, 1995, 1990, 1982, 1977, 1973, 1969 by Mosby, an imprint of Elsevier Inc.
PFT Report Interpretation
• FEV1/FVC ratio is good place to start; reduced (<70%) with obstructive lung disease
• If TLC less than 80% of predicted normal & FEV1/FVC is normal - restrictive disease is present
• If DLCO is <80% of normal - diffusion defect is presentReduced surface area = emphysemaThickened AC membrane = pulmonary fibrosis
47
Copyright © 2013, 2009, 2003, 1999, 1995, 1990, 1982, 1977, 1973, 1969 by Mosby, an imprint of Elsevier Inc.
PFT Report Interpretation
48
Copyright © 2013, 2009, 2003, 1999, 1995, 1990, 1982, 1977, 1973, 1969 by Mosby, an imprint of Elsevier Inc.
Interpretation
49